The specific aims for this Project are focused on a single overarching hypothesis that PGE2 inhibits infiltration of the airway with the inflammatory cells which cause bronchoconstriction in atopic asthmatics. The hypothesis is based on evidence that inhaled PGE2 completely prevents acute and late allergic bronchoconstriction. The experiments in this Project I have been planned in concert with those of Breyer's Project where the role of EP2 receptors in airway constriction and inflammation also will be examined. The overall hypothesis will be addressed by three specific aims. The hypothesis that inhaled PGE2 inhibits the mast cell activation associated with acute allergic bronchoconstriction will be tested in patients with asthma, examining mast cell degranulation, lipid mediator release and cytokine formation. In purified human lung mast cells, the effects of PGE2 on activation-induced cytokine formation will be examined further and the EP receptor subtype responsible for inhibiting activation will be characterized. The second specific aim examines the hypothesis that PGE2 inhibits late allergic bronchoconstriction by inhibiting the cytokine signaling system that leads to eosinophil infiltration in the airway, and that the predominant effect of PGE2 on this signaling system is through cells other than the mast cell. The effect of PGE2 on the IL-5 signaling cascade and inflammation associated with late allergic bronchoconstriction will specifically be examined. To provide evidence the inhibition of the late phase by PGE2 is not mediated by its effect on the mast cell, studies with a beta-adrenergic agonist, which also blocks mast cell activation through a G coupled receptor in vitro will be employed as an investigational tool. It is hypothesized that the beta-agonist will inhibit mast cell activation but will not prevent athe late phase airway infiltration and bronchoconstriction. The EP receptor subtypes on the cells of the asthmatic airway will be characterized to further elucidate the cellular mechanism for inhibition of late bronchoconstriction by PGE2. In addition to the mast cell, EP receptor subtypes will be examined on the alveolar macrophage, dendritic cells and T-lymphocytes. Because athe antigen presenting dendritic cell activates T-lymphocytes to produce Il-4 and Il-5, the effects of PGE2 on this function of the dendritic cell will be investigated. As a late allergic bronchoconstriction is considered to be a model for the airway dysfunction in chronic asthma, the effect of continuing administration of PGE2 on the airway inflammatory infiltrate and hyperreactivity in patients with asthma will be examined.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
3P50GM015431-32S1
Application #
6217824
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
32
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Salisbury-Ruf, Christi T; Bertram, Clinton C; Vergeade, Aurelia et al. (2018) Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. Elife 7:
Kong, Deping; Li, Juanjuan; Shen, Yujun et al. (2017) Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1. J Pharmacol Exp Ther 360:435-444
Teder, Tarvi; Boeglin, William E; Brash, Alan R (2017) Oxidation of C18 Hydroxy-Polyunsaturated Fatty Acids to Epoxide or Ketone by Catalase-Related Hemoproteins Activated with Iodosylbenzene. Lipids 52:587-597
Plewes, Katherine; Kingston, Hugh W F; Ghose, Aniruddha et al. (2017) Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study. BMC Infect Dis 17:313
Kudalkar, Shalley N; Kingsley, Philip J; Marnett, Lawrence J (2016) Assay of Endocannabinoid Oxidation by Cyclooxygenase-2. Methods Mol Biol 1412:205-15
Wu, Jing; Montaniel, Kim Ramil C; Saleh, Mohamed A et al. (2016) Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension. Hypertension 67:461-8
Wu, Jing; Saleh, Mohamed A; Kirabo, Annet et al. (2016) Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest 126:50-67
Mashhadi, Zahra; Newcomer, Marcia E; Brash, Alan R (2016) The Thr-His Connection on the Distal Heme of Catalase-Related Hemoproteins: A Hallmark of Reaction with Fatty Acid Hydroperoxides. Chembiochem 17:2000-2006
Kong, Deping; Shen, Yujun; Liu, Guizhu et al. (2016) PKA regulatory II? subunit is essential for PGD2-mediated resolution of inflammation. J Exp Med 213:2209-26
Boutaud, Olivier; Sosa, I Romina; Amin, Taneem et al. (2016) Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. Cancer Prev Res (Phila) 9:855-865

Showing the most recent 10 out of 147 publications